feed,title,long_url,short_url
Benzinga,"There Is Significant Upside To WeWork Stock, Analyst Says: 'Demand Is Robust'",https://benzinga.com/analyst-ratings/analyst-color/22/10/29379022/there-is-significant-upside-to-wework-stock-analyst-says-demand-is-robust,https://bit.ly/3srOXU1
Benzinga,Alpine Immune Sciences Stops Davoceticept Trials In Cancer Indications After Second Patient Death,https://benzinga.com/general/biotech/22/10/29379449/alpine-immune-sciences-stops-davoceticept-trials-in-cancer-indications-after-second-patient-death,https://bit.ly/3D0qoCj
